home / stock / lly / lly news


LLY News and Press, Eli Lilly and Company From 02/06/24

Stock Information

Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com

Menu

LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...

LLY - Eli Lilly in charts: Verzenio and Mounjaro drive revenue growth, while Humalog and Trulicity decline

2024-02-06 07:28:18 ET More on Eli Lilly, Eli Lilly and Company, etc. Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly beats in Q4 a...

LLY - Eli Lilly beats Q4 estimates on solid demand for weight-loss drug

2024-02-06 07:02:45 ET Eli Lilly & Co (NYSE: LLY) is trading up in premarket on Tuesday after coming in ahead of Street estimates in its fiscal fourth quarter on a solid launch of Zepbound (weight-loss drug) and higher prices for Mounjaro (diabetes drugs). Investors are pleased ...

LLY - Eli Lilly beats top-line and bottom-line estimates; initiates FY24 outlook

2024-02-06 06:47:47 ET More on Eli Lilly Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly Q4 results to highlight Zepbound uptake ...

LLY - Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance

Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance PR Newswire Revenue in Q4 2023 increased 28%. New Products (i) revenue grew by $2.19 billion to $2.49 billion in Q4 2023, led by Mounjaro and Zepbound. Growth Products (ii) ...

LLY - Expected US Company Earnings on Tuesday, February 6th, 2024

Algoma Steel Group Inc. (ASTL) is expected to report for Q3 2024 CTS Corporation (CTS) is expected to report for Q4 2023 Xylem Inc. New (XYL) is expected to report $0.96 for Q4 2023 TIM S.A. American Depositary Shares (Each representing 5) (TIMB) is expected to report for Q4 2023 ...

LLY - Overweight Recommendation Issued On LLY By Morgan Stanley

2024-02-06 02:30:02 ET Morgan Stanley analyst issues OVERWEIGHT recommendation for LLY on February 6, 2024 01:05AM ET. The previous analyst recommendation was Overweight. LLY was trading at $706.2 at issue of the analyst recommendation. The overall analyst consensus : BU...

LLY - (LLY) Trading Advice

2024-02-06 01:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

LLY - Not All Of Big Tech Posted Magnificent Results For Q4 2023

2024-02-06 01:10:00 ET Summary Some big tech results fizzled, but there were two standouts last week. Nine S&P 500® companies have outlier earnings dates this week - MCD, IEX, EW, MAA, MCK, HSY, COP, TROW, CTLT. 1,558 companies are expected to report during the second...

LLY - Canadian Companies Moving the Markets, Evening edition
Mon, Feb 05, 2024 as of 4:00 pm ET

A look at the top 10 most actives in Canada Fission Uranium Corp. (FCU) fell 10.0% to $1.17 on volume of 18,269,621 shares Baytex Energy Corp. (BTE) fell 1.5% to $4 on volume of 6,762,423 shares Cenovus Energy Inc. (CVE) rose 0.1% to $21.36 on volume of 6,043,045 shares TELUS Corporatio...

LLY - Eli Lilly Q4 results to highlight Zepbound uptake

2024-02-05 12:38:30 ET More on Eli Lilly Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly sees highest intraday trade since November...

Previous 10 Next 10